Tyler J Wilhite
Overview
Explore the profile of Tyler J Wilhite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee A, Epperly M, Fisher R, Hou W, Shields D, Huq M, et al.
Cell Death Discov
. 2023 Jul;
9(1):252.
PMID: 37460469
Cellular senescence is involved in the development of pulmonary fibrosis as well as in lung tissue repair and regeneration. Therefore, a strategy of removal of senescent cells by senolytic drugs...
2.
Sebastian N, Webb A, Merrell K, Koay E, Wolfe A, Zhang L, et al.
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680317
Background: Optimal patient selection for radiotherapy in pancreatic ductal adenocarcinoma (PDAC) is unestablished. Molecular profiling may select patients at high risk for locoregional recurrence (LRR) who would benefit from radiation....
3.
Wilhite T, Routman D, Arnett A, Glasgow A, Habermann E, Pisansky T, et al.
Bladder (San Franc)
. 2020 Aug;
5(3):e34.
PMID: 32775476
Objective: To assess recent utilization patterns of radiotherapy (RT) relative to cystectomy for muscle-invasive bladder cancer (MIBC) and evaluate survival trends over time in patients receiving RT. Materials And Methods:...
4.
Jethwa K, Hellekson C, Evans J, Harmsen W, Wilhite T, Whitaker T, et al.
Adv Radiat Oncol
. 2019 Nov;
4(4):659-667.
PMID: 31673659
Purpose: To assess gastrointestinal (GI) and genitourinary (GU) adverse events (AEs) of C-choline-positron emission tomography (CholPET) guided lymph node (LN) radiation therapy (RT) in patients who experience biochemical failure after...
5.
Garant A, Whitaker T, Spears G, Routman D, Harmsen W, Wilhite T, et al.
Pract Radiat Oncol
. 2019 Jul;
9(6):410-417.
PMID: 31310815
Purpose: The purpose of this study was to compare Functional Assessment of Cancer Therapy-Esophagus (FACT-E) questionnaire changes during proton (PRT) or photon (XRT) chemoradiation therapy (CRT) for esophageal cancer (EC)....
6.
Wilhite T, Youland R, Tian S, Finley R, Sarkaria J, Corbin K
Clin Breast Cancer
. 2019 Apr;
19(3):e400-e405.
PMID: 31031124
No abstract available.
7.
Bang A, Wilhite T, Pike L, Cagney D, Aizer A, Taylor A, et al.
Int J Radiat Oncol Biol Phys
. 2017 May;
98(2):344-351.
PMID: 28463153
Purpose: To analyze immune-related adverse events (ir-AEs) in patients treated with radiation and immune checkpoint blockade. Methods And Materials: We retrospectively reviewed records from patients with metastatic non-small cell lung...
8.
Chandra R, Wilhite T, Balboni T, Alexander B, Spektor A, Ott P, et al.
Oncoimmunology
. 2015 Oct;
4(11):e1046028.
PMID: 26451318
Case reports and preclinical data suggest radiotherapy and immunotherapy may synergize to generate "abscopal" responses outside the radiation field. This phenomenon remains relatively unexplored, prompting our systematic evaluation of metastatic...
9.
Aizer A, Wilhite T, Chen M, Graham P, Choueiri T, Hoffman K, et al.
Cancer
. 2014 May;
120(10):1532-9.
PMID: 24863392
Background: To the authors' knowledge, it remains unknown whether race-based differences in cancer outcomes have changed with time. In the current study, the authors assessed whether racial disparities in cancer-specific...
10.
Aizer A, Chen M, McCarthy E, Mendu M, Koo S, Wilhite T, et al.
J Clin Oncol
. 2013 Sep;
31(31):3869-76.
PMID: 24062405
Purpose: To examine the impact of marital status on stage at diagnosis, use of definitive therapy, and cancer-specific mortality among each of the 10 leading causes of cancer-related death in...